生物製剤およびバイオシミラーの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2021)

GlobalInfoResearchが発行した調査報告書(GIR703030326)
◆英語タイトル:Global Biologics and Biosimilars Market by Manufacturers, Regions, Type and Application, Forecast to 2021
◆商品コード:GIR703030326
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2016年12月6日
◆ページ数:110
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,480 ⇒換算¥393,240見積依頼/購入/質問フォーム
Corporate UserUSD4,680 ⇒換算¥528,840見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、生物製剤およびバイオシミラーの世界市場について調査・分析し、生物製剤およびバイオシミラーの世界市場概観、メーカー動向、メーカー別生物製剤およびバイオシミラーシェア、市場規模推移、市場規模予測、生物製剤およびバイオシミラー種類別分析(抗体、ホルモン、成長因子、その他)、生物製剤およびバイオシミラー用途別分析(腫瘍、糖尿病、心臓血管、血友病、その他)、主要地域分析(北米、欧州、アジア)、主要国分析データなどを含め、以下の構成でお届け致します。
・生物製剤およびバイオシミラーの市場概観
・生物製剤およびバイオシミラーのメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・生物製剤およびバイオシミラーのメーカー別販売動向、市場シェア、市場集中度、競争動向
・生物製剤およびバイオシミラーの世界市場規模
・生物製剤およびバイオシミラーの北米市場分析(アメリカ、カナダ、メキシコ等)
・生物製剤およびバイオシミラーのアメリカ市場規模推移
・生物製剤およびバイオシミラーのカナダ市場規模推移
・生物製剤およびバイオシミラーのメキシコ市場規模推移
・生物製剤およびバイオシミラーのヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・生物製剤およびバイオシミラーのドイツ市場規模推移
・生物製剤およびバイオシミラーのイギリス市場規模推移
・生物製剤およびバイオシミラーのロシア市場規模推移
・生物製剤およびバイオシミラーのアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・生物製剤およびバイオシミラーの日本市場規模推移
・生物製剤およびバイオシミラーの中国市場規模推移
・生物製剤およびバイオシミラーの韓国市場規模推移
・生物製剤およびバイオシミラーのインド市場規模推移
・生物製剤およびバイオシミラーの東南アジア市場規模推移
・生物製剤およびバイオシミラーの南米・中東・アフリカ市場分析
・生物製剤およびバイオシミラーの種類別分析/市場規模推移(抗体、ホルモン、成長因子、その他)
・生物製剤およびバイオシミラーの用途別分析/市場規模推移(腫瘍、糖尿病、心臓血管、血友病、その他)
・生物製剤およびバイオシミラーの市場予測(地域別予測、種類別予測、用途別予測)
・生物製剤およびバイオシミラーの販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

“A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product’s patent expires.

Scope of the Report:
This report focuses on the Biologics and Biosimilars in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa

Market Segment by Type, covers
Antibody
Hormone
Growth Factors
Other

Market Segment by Applications, can be divided into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other

There are 13 Chapters to deeply display the global Biologics and Biosimilars market.

Chapter 1, to describe Biologics and Biosimilars Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Biologics and Biosimilars, with sales, revenue, and price of Biologics and Biosimilars, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Biologics and Biosimilars, for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, Biologics and Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe Biologics and Biosimilars sales channel, distributors, traders, dealers, appendix and data source.

【レポートの目次】

Table of Contents

Global Biologics and Biosimilars Market by Manufacturers, Regions, Type and Application, Forecast to 2021
1 Market Overview
1.1 Biologics and Biosimilars Introduction
1.2 Market Analysis by Type
1.2.1 Antibody
1.2.2 Hormone
1.2.3 Growth Factors
1.3 Market Analysis by Applications
1.3.1 Tumor
1.3.2 Diabetes
1.3.3 Cardiovascular
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA
1.4.1.2 Canada
1.4.1.3 Mexico
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany
1.4.2.2 France
1.4.2.3 UK
1.4.2.4 Russia
1.4.2.5 Italy
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China
1.4.3.2 Japan
1.4.3.3 Korea
1.4.3.4 India
1.4.3.5 Southeast Asia
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil
1.4.4.2 Egypt
1.4.4.3 Saudi Arabia
1.4.4.4 South Africa
1.4.4.5 Nigeria
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Biologics and Biosimilars Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share
2.2 Amgen
2.2.1 Business Overview
2.2.2 Biologics and Biosimilars Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share
2.3 AbbVie
2.3.1 Business Overview
2.3.2 Biologics and Biosimilars Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share
2.4 Sanofi-Aventis
2.4.1 Business Overview
2.4.2 Biologics and Biosimilars Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share
2.5 Johnson & Johnson
2.5.1 Business Overview
2.5.2 Biologics and Biosimilars Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Biologics and Biosimilars Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share
2.7 Novo Nordisk
2.7.1 Business Overview
2.7.2 Biologics and Biosimilars Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share
2.8 Eli Lilly
2.8.1 Business Overview
2.8.2 Biologics and Biosimilars Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share
2.9 Novartis
2.9.1 Business Overview
2.9.2 Biologics and Biosimilars Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share
2.10 Merck
2.10.1 Business Overview
2.10.2 Biologics and Biosimilars Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share
2.11 3sbio
2.11.1 Business Overview
2.11.2 Biologics and Biosimilars Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share
2.12 Changchun High Tech
2.12.1 Business Overview
2.12.2 Biologics and Biosimilars Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share
2.13 CP Guojian
2.13.1 Business Overview
2.13.2 Biologics and Biosimilars Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share
2.14 Biotech
2.14.1 Business Overview
2.14.2 Biologics and Biosimilars Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share
2.15 Gelgen
2.15.1 Business Overview
2.15.2 Biologics and Biosimilars Type and Applications
2.15.2.1 Type 1
2.15.2.2 Type 2
2.15.3 Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share
2.16 Innovent
2.16.1 Business Overview
2.16.2 Biologics and Biosimilars Type and Applications
2.16.2.1 Type 1
2.16.2.2 Type 2
2.16.3 Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share
2.17 Dong Bao
2.17.1 Business Overview
2.17.2 Biologics and Biosimilars Type and Applications
2.17.2.1 Type 1
2.17.2.2 Type 2
2.17.3 Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share
2.18 Ganlee
2.18.1 Business Overview
2.18.2 Biologics and Biosimilars Type and Applications
2.18.2.1 Type 1
2.18.2.2 Type 2
2.18.3 Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share
2.19 United Laboratories
2.19.1 Business Overview
2.19.2 Biologics and Biosimilars Type and Applications
2.19.2.1 Type 1
2.19.2.2 Type 2
2.19.3 United Laboratories Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share
3 Global Biologics and Biosimilars Market Competition, by Manufacturer
3.1 Global Biologics and Biosimilars Sales and Market Share by Manufacturer
3.2 Global Biologics and Biosimilars Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Biologics and Biosimilars Manufacturer Market Share
3.3.2 Top 6 Biologics and Biosimilars Manufacturer Market Share
3.4 Market Competition Trend
4 Global Biologics and Biosimilars Market Analysis by Regions
4.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Regions
4.1.1 Global Biologics and Biosimilars Sales by Regions (2011-2016)
4.1.2 Global Biologics and Biosimilars Revenue by Regions (2011-2016)
4.2 North America Biologics and Biosimilars Sales and Growth (2011-2016)
4.3 Europe Biologics and Biosimilars Sales and Growth (2011-2016)
4.4 Asia-Pacific Biologics and Biosimilars Sales and Growth (2011-2016)
4.5 South America Biologics and Biosimilars Sales and Growth (2011-2016)
4.6 Middle East and Africa Biologics and Biosimilars Sales and Growth (2011-2016)
5 North America Biologics and Biosimilars by Countries
5.1 North America Biologics and Biosimilars Sales, Revenue and Market Share by Countries
5.1.1 North America Biologics and Biosimilars Sales by Countries (2011-2016)
5.1.2 North America Biologics and Biosimilars Revenue by Countries (2011-2016)
5.2 USA Biologics and Biosimilars Sales and Growth (2011-2016)
5.3 Canada Biologics and Biosimilars Sales and Growth (2011-2016)
5.4 Mexico Biologics and Biosimilars Sales and Growth (2011-2016)
6 Europe Biologics and Biosimilars by Countries
6.1 Europe Biologics and Biosimilars Sales, Revenue and Market Share by Countries
6.1.1 Europe Biologics and Biosimilars Sales by Countries (2011-2016)
6.1.2 Europe Biologics and Biosimilars Revenue by Countries (2011-2016)
6.2 Germany Biologics and Biosimilars Sales and Growth (2011-2016)
6.3 UK Biologics and Biosimilars Sales and Growth (2011-2016)
6.4 France Biologics and Biosimilars Sales and Growth (2011-2016)
6.5 Russia Biologics and Biosimilars Sales and Growth (2011-2016)
6.6 Italy Biologics and Biosimilars Sales and Growth (2011-2016)
7 Asia-Pacific Biologics and Biosimilars by Countries
7.1 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Biologics and Biosimilars Sales by Countries (2011-2016)
7.1.2 Asia-Pacific Biologics and Biosimilars Revenue by Countries (2011-2016)
7.2 China Biologics and Biosimilars Sales and Growth (2011-2016)
7.3 Japan Biologics and Biosimilars Sales and Growth (2011-2016)
7.4 Korea Biologics and Biosimilars Sales and Growth (2011-2016)
7.5 India Biologics and Biosimilars Sales and Growth (2011-2016)
7.6 Southeast Asia Biologics and Biosimilars Sales and Growth (2011-2016)
8 South America, Middle East and Africa Biologics and Biosimilars by Countries
8.1 South America, Middle East and Africa Biologics and Biosimilars Sales, Revenue and Market Share by Countries
8.1.1 South America, Middle East and Africa Biologics and Biosimilars Sales by Countries (2011-2016)
8.1.2 South America, Middle East and Africa Biologics and Biosimilars Revenue by Countries (2011-2016)
8.2 Brazil Biologics and Biosimilars Sales and Growth (2011-2016)
8.3 Saudi Arabia Biologics and Biosimilars Sales and Growth (2011-2016)
8.4 Egypt Biologics and Biosimilars Sales and Growth (2011-2016)
8.5 Nigeria Biologics and Biosimilars Sales and Growth (2011-2016)
8.6 South Africa Biologics and Biosimilars Sales and Growth (2011-2016)
9 Biologics and Biosimilars Market Segment by Type
9.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Type (2011-2016)
9.1.1 Global Biologics and Biosimilars Sales and Market Share by Type (2011-2016)
9.1.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2011-2016)
9.2 Antibody Sales Growth and Price
9.2.1 Global Antibody Sales Growth (2011-2016)
9.2.2 Global Antibody Price (2011-2016)
9.3 Hormone Sales Growth and Price
9.3.1 Global Hormone Sales Growth (2011-2016)
9.3.2 Global Hormone Price (2011-2016)
9.4 Growth Factors Sales Growth and Price
9.4.1 Global Growth Factors Sales Growth (2011-2016)
9.4.2 Global Growth Factors Price (2011-2016)
10 Biologics and Biosimilars Market Segment by Application
10.1 Global Biologics and Biosimilars Sales Market Share by Application (2011-2016)
10.2 Tumor Sales Growth (2011-2016)
10.3 Diabetes Sales Growth (2011-2016)
10.4 Cardiovascular Sales Growth (2011-2016)
10.5 Hemophilia Sales Growth (2011-2016)
11 Biologics and Biosimilars Market Forecast (2016-2021)
11.1 Global Biologics and Biosimilars Sales, Revenue and Growth Rate (2016-2021)
11.2 Biologics and Biosimilars Market Forecast by Regions (2016-2021)
11.3 Biologics and Biosimilars Market Forecast by Type (2016-2021)
11.4 Biologics and Biosimilars Market Forecast by Application (2016-2021)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Future Trend
12.2 Distributors, Traders and Dealers
13 Appendix
13.1 Methodology
13.2 Analyst Introduction
13.3 Data Source

List of Tables and Figures
Figure Biologics and Biosimilars Picture
Figure Global Sales Market Share of Biologics and Biosimilars by Types in 2015
Table Biologics and Biosimilars Types for Major Manufacturers
Figure Antibody Picture
Figure Hormone Picture
Figure Growth Factors Picture
Table Biologics and Biosimilars Sales Market Share by Applications in 2015
Table Roche Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table 3sbio Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Changchun High Tech Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table CP Guojian Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Biotech Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Gelgen Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Innovent Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Dong Bao Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Ganlee Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table United Laboratories Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table United Laboratories Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table Biologics and Biosimilars Type and Applications
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Global Biologics and Biosimilars Sales by Manufacturer (2015-2016)
Figure Global Biologics and Biosimilars Sales Market Share by Manufacturer in 2015
Figure Global Biologics and Biosimilars Sales Market Share by Manufacturer in 2016
Table Global Biologics and Biosimilars Revenue by Manufacturer (2015-2016)
Figure Global Biologics and Biosimilars Revenue Market Share by Manufacturer in 2015
Figure Global Biologics and Biosimilars Revenue Market Share by Manufacturer in 2016
Figure Global Biologics and Biosimilars Sales and Growth (2011-2016)
Figure Global Biologics and Biosimilars Revenue and Growth (2011-2016)
Table Global Biologics and Biosimilars Sales by Regions (2011-2016)
Table Global Biologics and Biosimilars Sales Market Share by Regions (2011-2016)
Table Global Biologics and Biosimilars Revenue by Regions (2011-2016)
Table Global Biologics and Biosimilars Revenue Market Share by Regions (2011-2016)
Figure North America Biologics and Biosimilars Sales and Growth (2011-2016)
Figure Europe Biologics and Biosimilars Sales and Growth (2011-2016)
Figure Asia-Pacific Biologics and Biosimilars Sales and Growth (2011-2016)
Figure South America Biologics and Biosimilars Sales and Growth (2011-2016)
Figure Middle East and Africa Biologics and Biosimilars Sales and Growth (2011-2016)
Figure North America Biologics and Biosimilars Revenue and Growth (2011-2016)
Table North America Biologics and Biosimilars Sales by Countries (2011-2016)
Table North America Biologics and Biosimilars Sales Market Share by Countries (2011-2016)
Table North America Biologics and Biosimilars Revenue by Countries (2011-2016)
Table North America Biologics and Biosimilars Revenue Market Share by Countries (2011-2016)
Figure USA Biologics and Biosimilars Sales and Growth (2011-2016)
Figure Canada Biologics and Biosimilars Sales and Growth (2011-2016)
Figure Mexico Biologics and Biosimilars Sales and Growth (2011-2016)
Figure Europe Biologics and Biosimilars Revenue and Growth (2011-2016)
Table Europe Biologics and Biosimilars Sales by Countries (2011-2016)
Table Europe Biologics and Biosimilars Sales Market Share by Countries (2011-2016)
Table Europe Biologics and Biosimilars Revenue by Countries (2011-2016)
Table Europe Biologics and Biosimilars Revenue Market Share by Countries (2011-2016)
Figure Germany Biologics and Biosimilars Sales and Growth (2011-2016)
Figure UK Biologics and Biosimilars Sales and Growth (2011-2016)
Figure France Biologics and Biosimilars Sales and Growth (2011-2016)
Figure Russia Biologics and Biosimilars Sales and Growth (2011-2016)
Figure Italy Biologics and Biosimilars Sales and Growth (2011-2016)
Figure Asia-Pacific Biologics and Biosimilars Revenue and Growth (2011-2016)
Table Asia-Pacific Biologics and Biosimilars Sales by Countries (2011-2016)
Table Asia-Pacific Biologics and Biosimilars Sales Market Share by Countries (2011-2016)
Table Asia-Pacific Biologics and Biosimilars Revenue by Countries (2011-2016)
Table Asia-Pacific Biologics and Biosimilars Revenue Market Share by Countries (2011-2016)
Figure China Biologics and Biosimilars Sales and Growth (2011-2016)
Figure Japan Biologics and Biosimilars Sales and Growth (2011-2016)
Figure Korea Biologics and Biosimilars Sales and Growth (2011-2016)
Figure India Biologics and Biosimilars Sales and Growth (2011-2016)
Figure Southeast Asia Biologics and Biosimilars Sales and Growth (2011-2016)
Figure South America, Middle East and Africa Biologics and Biosimilars Revenue and Growth (2011-2016)
Table South America, Middle East and Africa Biologics and Biosimilars Sales by Countries (2011-2016)
Table South America, Middle East and Africa Biologics and Biosimilars Sales Market Share by Countries (2011-2016)
Table South America, Middle East and Africa Biologics and Biosimilars Revenue by Countries (2011-2016)
Table South America, Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries (2011-2016)
Figure Brazil Biologics and Biosimilars Sales and Growth (2011-2016)
Figure Saudi Arabia Biologics and Biosimilars Sales and Growth (2011-2016)
Figure Egypt Biologics and Biosimilars Sales and Growth (2011-2016)
Figure Nigeria Biologics and Biosimilars Sales and Growth (2011-2016)
Figure South Africa Biologics and Biosimilars Sales and Growth (2011-2016)
Table Global Biologics and Biosimilars Sales by Type (2011-2016)
Table Global Biologics and Biosimilars Sales Share by Type (2011-2016)
Table Global Biologics and Biosimilars Revenue by Type (2011-2016)
Table Global Biologics and Biosimilars Revenue Share by Type (2011-2016)
Figure Global Antibody Sales Growth (2011-2016)
Figure Global Antibody Price (2011-2016)
Figure Global Hormone Sales Growth (2011-2016)
Figure Global Hormone Price (2011-2016)
Figure Global Growth Factors Sales Growth (2011-2016)
Figure Global Growth Factors Price (2011-2016)
Table Global Biologics and Biosimilars Sales by Application (2011-2016)
Table Global Biologics and Biosimilars Sales Share by Application (2011-2016)
Figure Global Tumor Sales Growth (2011-2016)
Figure Global Diabetes Sales Growth (2011-2016)
Figure Global Cardiovascular Sales Growth (2011-2016)
Figure Global Hemophilia Sales Growth (2011-2016)
Figure Global Biologics and Biosimilars Sales, Revenue and Growth Rate (2016 -2021)
Table Global Biologics and Biosimilars Sales Forecast by Regions (2016-2021)
Table Global Biologics and Biosimilars Market Share Forecast by Regions (2016-2021)
Table Global Biologics and Biosimilars Sales Forecast by Type (2016-2021)
Table Global Biologics and Biosimilars Market Share Forecast by Type (2016-2021)
Table Global Biologics and Biosimilars Sales Forecast by Application (2016-2021)
Table Global Biologics and Biosimilars Market Share Forecast by Application (2016-2021)
Table Distributors/Traders/ Dealers List

【レポートのキーワード】

生物製剤およびバイオシミラー、抗体、ホルモン、成長因子、腫瘍、糖尿病、心臓血管、血友病

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 生物製剤およびバイオシミラーの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2021)(Global Biologics and Biosimilars Market by Manufacturers, Regions, Type and Application, Forecast to 2021)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆